Welcome to the e-CCO Library!

P102: A small molecule selective integrin α4β7 inhibitor demonstrates efficacy in a chronic model of Inflammatory Bowel Disease
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Redhu, N.S.(1)*;Rowe, M.(1);Lee, D.(2);Jain, D.(1);Sang, A.(1);Granata, D.(1);Harrison, B.(3);Cui, D.(2);Bursavich, M.(3);Ray, A.S.(1);Lippa, B.(3);Rogers, B.N.(3);Wong , J.(1);
Created: Friday, 14 July 2023, 10:48 AM
P102: Changes in serum immune protein profiles following vedolizumab therapy in Inflammatory Bowel Disease.
Year: 2022
Source: ECCO'22
Authors: O'Connell, J.(1,2);O'Connell, F.(2);O'Sullivan, J.(2);Kevans, D.(1,2,3);
Created: Friday, 11 February 2022, 3:52 PM
P102: Hypoxia reduces inflammation through the downregulation of NLRP3/mTOR signaling and the activation of autophagy
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Cosin-Roger J.*1, Simmen S.1, Melhem H.1, Atrott K.1, Frey-Wagner I.1, Hausmann M.1, de Vallière C.1, Spalinger M.R.1, Spielmann P.2,3, Wagner R.H.2,3, Zeitz J.1, Vavricka S.R.1, Rogler G.1, Ruiz P.A.1

Created: Wednesday, 20 February 2019, 10:36 AM
P102: Increased abundance of gut microbial virulence genes and pro-inflammatory pathways during Crohn’s disease exacerbations
Year: 2018
Source: ECCO '18 Vienna
Authors:

M. Klaassen*, F. Imhann, V. Collij, A. Vich Vila, R. Gacesa, J. Fu, A. Zhernakova, C. Wijmenga, R. Weersma

Created: Thursday, 21 February 2019, 9:14 AM
P102: Outcomes of coronavirus disease 2019 among patients with inflammatory bowel diseases and the influence of IBD-related medications– A Danish prospective population-based cohort study
Year: 2021
Source: ECCO'21 Virtual
Authors: Attauabi, M.(1,2,3);Poulsen, A.(4);Kajbæk Verner-Andersen, M.(5);Rosager Hansen, M.(6);Pedersen, N.(7);Pilegaard Prahm, A.(4);Berg Lødrup, A.(8);Haderselv, K.(9);Larsen, L.(10);Jess, T.(10,11);Glerup, H.(12);Molazahi, A.(13);Mathiassen Oppfeldt, A.(14);Dahlerup, J.F.(15);Lodberg Hvas, C.(15);Neumann, A.(16);Wase, A.(16);Dam Jensen, M.(17);Nathan, T.(17);Jensen, S.(17);Theede, K.(1,3);Kiszka-Kanowitz, M.(1,3);Benedict Seidelin, J.(2);Burisch, J.(1,3);
Created: Wednesday, 2 June 2021, 4:12 PM
P102: Subclinical atherosclerosis assessed by coronary artery calcium score in patients with Crohn’s disease
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

B. Rocha*1, C. Nomura2, M. Rocha2, B. Lopes2, M. Azevedo1, A. Carlos1, F. Carrillo1, A. Damiao1, A. Sipahi1, A. Leite1

Created: Friday, 22 February 2019, 9:41 AM
P103 The treatment effect of tonsil-derived mesenchymal stem cells (T-MSCs) via regulating programmed death-1/programmed death ligand-1 (PD-1/PD-L1) in ulcerative colitis
Year: 2020
Source:

ECCO'20 Vienna

Authors:

E.M. Song, Y.H. Joo, J.Y. Lim, A.R. Choe, C.H. Tae, C.M. Moon, S.E. Kim, H.K. Jung, K.N. Shim, S.A. Jung

Created: Thursday, 30 January 2020, 10:12 AM
P103: Colitis-associated faecal miRNAs are mediators of host-microbiota interactions and key regulators of intestinal permeability and inflammation
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Casado-Bedmar, M.(1)*;Roy, M.(1);Hugot, J.P.(1);Le Gall, M.(1);Chassaing, B.(2);Viennois, E.(1);
Created: Friday, 14 July 2023, 10:48 AM
P103: Degradation and formation of type III, IV and V collagen are associated with disease activity, disease severity and disease extension in patients with ulcerative colitis
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

J. H. Mortensen*1, V. Domislovic2, M. A. Karsdal1, M. Brinar2, Z. Krznaric2, T. Manon-Jensen1

Created: Friday, 22 February 2019, 9:41 AM
P103: Evaluation of efficacy of new vectors for siRNA CYCLIN D1 and E2F1 delivery in control of cancer progression in inflammatory bowel disease
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Russo I.*1, Bochicchio S.2, Piazza O.3, Barba A.A.2, Lamberti G.4, Carrizzo A.5, Zeppa P.6, Vecchione C.6, Iovino P.6, Ciacci C.6

Created: Wednesday, 20 February 2019, 10:36 AM
P103: Identifying CES-1 positive myeloid cells with mass cytometry as a potential therapeutic target for Crohn’s disease
Year: 2022
Source: ECCO'22
Authors: HagemanMD, I.(1);Elfiky, A.(2);Becker, M.(2);Joustra, V.(1);Buskens, C.(3);Li Yim, A.(2);Hakvoort, T.(2);Verhoeff, J.(4);Garcia Vallejo, J.(4);D'Haens, G.(1);Wildenberg, M.(2);De Jonge, W.(2);
Created: Friday, 11 February 2022, 3:52 PM
P103: Minimal Clinically Important Difference (MCID) for the Ulcerative Colitis Patient-Reported Outcomes Signs and Symptoms (UC-PRO/SS) Tool
Year: 2021
Source: ECCO'21 Virtual
Authors: Pulley, J.(1);Galloway, D.(1);Oh, Y.(2);Devine, J.(3);Petrek, H.(2);Khavarian, A.(2);Matsui, A.(3);
Created: Wednesday, 2 June 2021, 4:12 PM
P103: Selective M1 macrophage polarisation in Crohn’s disease in comparison to intestinal tuberculosis: a novel observation
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

P. Das1, S. Pilli2, T. Kumar1, R. Rampal2, I. A. Khan2, A.K. Singh2, D. Kumar3, V. Ahuja*2

Created: Friday, 22 February 2019, 9:49 AM
P103: The identification of lesion-specific gene expression in intestinal epithelial cells of ulcerative colitis by comparing colonic organoids from lesion and non-lesion parts of same patients
Year: 2018
Source: ECCO '18 Vienna
Authors:

R. Nishimura1*, K. Tsuchiya1, T. Shirasaki1, S. Watanabe1, S. Hibiya1, R. Okamoto2, T. Nakamura3, M. Watanabe1

Created: Thursday, 21 February 2019, 9:14 AM
P104 Defective metabolism mediates NK cell dysfunction in inflammatory bowel disease (IBD)
Year: 2020
Source:

ECCO'20 Vienna

Authors:

V. Zaiatz Bittencourt1, E. Ryan2, F. Jones1, G. Doherty1

Created: Thursday, 30 January 2020, 10:12 AM
P104: Exploring the transcriptomic miRNA signatures of Egyptian Inflammatory Bowel Disease patients
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Khaled, M.(1)*;Hamdy, K.(2);Abou-Aisha, K.(3);Mansour, M.(4);
Created: Friday, 14 July 2023, 10:48 AM
P104: Gene expression profiles in inflamed colonic biopsies from newly diagnosed Crohn’s disease and ulcerative colitis patients differ depending on the age at diagnosis
Year: 2018
Source: ECCO '18 Vienna
Authors:

S. Verstockt1*, B. Verstockt2,3, J. Van Bouwel4,5, W. Meert4,5, A. Cortes Calabuig5, V. Brys4,5, V. Ballet2, E. Glorieus6, M. De Decker7, G. Van Assche2,3, P. Hindryckx6, M. Ferrante2,3, D. Laukens6, F. Mana7, M. De Vos6, S. Vermeire2,3, I. Cleynen1

Created: Thursday, 21 February 2019, 9:14 AM
P104: Icariin Attenuates Intestinal Inflammation through Inhibition of the Nuclear Factor-ĸB signaling
Year: 2022
Source: ECCO'22
Authors: Soh, H.(1);Park, S.(2);Lee, H.J.(1);Koh, S.J.(1);Im, J.P.(1);Kim, J.S.(1);
Created: Friday, 11 February 2022, 3:52 PM
P104: Inflammatory complications of the pouch, and therapetic requirements after colectomy in patients with ulcerative colitis. Results from the RESERVO Study of GETECCU
Year: 2021
Source: ECCO'21 Virtual
Authors: Mesonero Gismero, F.(1);Zabana, Y.(2);Fernández-Clotet, A.(3);Sola, A.(4);Caballol, B.(3);Leo, E.(4);García, M.J.(5);Bertoletti, F.(6);Alejandro, M.(7);Suris, G.(8);Casis, B.(9);Ferreiro-Iglesias, R.(10);Calafat, M.(11);Jiménez, I.(12);Miranda-Bautista, J.(13);Lamuela, L.J.(14);Fajardo, I.(15);Torrealba, L.(16);Nájera, R.(17);Sáiz, R.M.(18);González, I.(19);Vicuña, M.(20);García-Morales, N.(21);Gutiérrez, A.(22);López-García, A.(23);Benítez, J.M.(24);Rubín de Célix, C.(25);Tejido, C.(26);Brunet, E.(27);Bastón, I.(10);Rodríguez-Lago, I.(12);Baltar, R.(28);Huguet, J.M.(29);Hermida, B.(30);Caballero-Mateos, A.(31);Sánchez-Guillén, L.(32);Bouhmidi, A.(33);Pajares, R.(34);López-Sanromán, A.(1);Barreiro-de Acosta, M.(10);
Created: Wednesday, 2 June 2021, 4:12 PM
P104: Monitoring inflammatory activity in Crohn’s disease: simple ultrasonographic score vs. CEUS which one to use?
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

C. Arieira*1,2,3, S. Monteiro1,2,3, F. Dias de Castro1,2,3, J. Magalhães1,2,3, S. Leite1,2,3, M. J. Moreira1,2,3, J. Cotter1,2,3

Created: Friday, 22 February 2019, 9:41 AM